Invesaro

Stocks LNSR Financial statements

Financial statements

LENSAR, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data LENSAR, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Revenue30.526.434.535.442.253.558.4
Cost of revenue17.312.316.615.421.127.631.3
Gross profit13.214.117.82021.125.927.1
Research and development7.577.5512.411.86.145.335.62
Selling, general and administrative17.123.823.927.226.126.545.2
Operating income-12.7-18.5-19.7-20.2-12.2-10.7-24.6
Interest expense21.34
Other non-operating income0.060.070.050.260.70.660.64
Pre-tax income-14.7-19.8-19.6-19.9-14.4-31.4-34.3
Net income-14.7-19.8-19.6-19.9-14.4-31.4-34.3
EBITDA-10.1-17.2-18.1-17.9-9.81-7.7-21
EPS, basic-13.70-4.28-2.09-1.96-1.31-2.73-2.87
EPS, diluted-13.70-4.28-2.09-1.96-1.31-2.73-2.87
Shares, basic (weighted)1.074.629.3710.21111.512
Shares, diluted (weighted)1.074.629.3710.21111.512

Balance sheet

FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents4.6240.631.614.720.616.313
Short-term investments3.446.195
Receivables3.382.014.646.0446.096.38
Inventory8.0613.56.4911.715.711.421.5
Other current assets0.621.861.71.062.371.620.6
Total current assets17.258.444.833.746.44246.8
Property, plant and equipment0.720.830.760.560.680.660.51
Lease right-of-use assets0.853.673.152.632.142.472.56
Intangible assets13.412.110.912.1116.115.19
Long-term investments0.49
Other non-current assets1.013.763.222.692.212.622.75
Total assets34.579.166.555.869.666.371.4
Accounts payable1.582.482.695.424.01619
Accrued liabilities4.784.574.64.75.726.817.77
Deferred revenue0.780.920.90.771.351.683.07
Total current liabilities7.838.478.7111.411.61540.6
Lease liabilities0.333.312.82.271.752.091.99
Other non-current liabilities0.310.130.070.170.570.70.91
Total liabilities65.111.911.613.922.447.783.7
Paid-in capital7.62125132139145148151
Retained earnings-38.2-58-77.6-97.5-112-143-178
Other comprehensive income00.010
Shareholders' equity-30.667.254.94233.44.86-26
Total equity-30.667.254.94233.44.86-26
Total liabilities and equity34.579.166.555.869.666.371.4
Shares outstanding1.0710.91111.111.311.712

Cash flow statement

FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Net income-14.7-19.8-19.6-19.9-14.4-31.4-34.3
Depreciation and amortization2.641.311.522.262.422.963.58
Stock-based compensation0.19.056.876.615.542.673.14
Change in receivables0.011.33-2.65-1.442.06-2.19-0.21
Change in inventory-4.77-8.72.33-6.89-7.46-4.9-13.9
Change in payables0.130.910.212.73-1.421.9613
Cash from operations-12.6-13.8-8.97-14.9-9.66-2.28-14.8
Capital expenditures-0.39-0.37-0.35-0.12-0.24-0.16-0.08
Purchases of investments-3.92-10.2-11.9
Sales and maturities of investments8.2413.2
Cash from investing-2.09-0.33-0.35-0.12-4.16-2.161.28
Stock issued16.40.060.09
Cash from financing15.9500.36-1.9919.80.0810.3
Net change in cash1.2735.9-8.96-175.95-4.36-3.29
Free cash flow-13-14.2-9.32-15-9.9-2.43-14.9
Interest paid0.470.48
Income taxes paid0.0200.020.020.04

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.92 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin48.3%Gross profit / revenue.
Operating margin-13.5%Operating income / revenue.
EBITDA margin-7.4%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin57.6%Net income / revenue.
Operating cash flow margin-12.1%Cash from operations / revenue.
Return on equity (ROE)232.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)49.9%Net income / average total assets.
Return on invested capital (ROIC)-479.1%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue8.8%Research and development expense / revenue.
SG&A / revenue51.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue4.6%Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue6.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y9.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y18.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y17.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y4.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y10.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y14.0%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-635.2%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y7.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y3.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y5.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y20.9%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.39xCurrent assets / current liabilities.
Quick ratio1.00x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.69x(Cash + short-term investments) / current liabilities.
Liabilities / assets58.8%Total liabilities / total assets.
Working capital$27.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets6.8%(Goodwill + intangible assets) / total assets.
Tangible book value$10.2MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.87xRevenue / average total assets.
Fixed asset turnover135xRevenue / average property, plant and equipment.
Inventory turnover1.25xCost of revenue / average inventory.
Days inventory292 days365 x average inventory / cost of revenue.
Receivables turnover9.77xRevenue / average receivables.
Days sales outstanding37 days365 x average receivables / revenue.
Days payables131 days365 x average accounts payable / cost of revenue.
Cash conversion cycle198 daysDays inventory + days sales outstanding - days payables.

Per share

MetricValueHow it is calculated
EPS, diluted$1.51Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$2.62Revenue / diluted weighted shares.
Operating cash flow per share-$0.32Cash from operations / diluted weighted shares.
Book value per share$1.21Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.83Tangible book value / shares outstanding.
Cash per share$1.10(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$85.0MShare price x shares outstanding.
Enterprise value$71.5MMarket cap + total debt - cash - short-term investments.
P/E2.45xMarket cap / net income. Only when net income is positive.
P/S1.41xMarket cap / revenue.
P/B5.70xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book8.36xMarket cap / tangible book value, when positive.
EV/Sales1.19xEnterprise value / revenue.
Earnings yield40.8%Net income / market cap (the inverse of P/E).
What was LENSAR, Inc.'s revenue in fiscal 2025?

LENSAR, Inc. reported revenue of $58.4M for fiscal 2025, 9.2% higher than the year before.

Was LENSAR, Inc. profitable in fiscal 2025?

No. It reported a net loss of $34.3M.

How much free cash flow did LENSAR, Inc. generate in fiscal 2025?

Cash from operations of $14.8M minus capital expenditures of $83.0K left free cash flow of -$14.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to LENSAR, Inc.